ReproCyc® PRRS EU

For active immunisation of breeding females from farms affected with PRRSV type I

ReproCyc® PRRS EU

Vaccine overview

  • Active immunisation of breeding females from farms affected with PRRSV type I
  • One 2 ml dose administered via a single intramuscular injection
  • Can be used in sows in mass vaccination programmes in all stages of the reproductive cycle (including gestation and lactation)
  • Onset of immunity at 5 weeks with a duration of 17 weeks
  • Adjuvanted vaccine with ImpranFLEX®

Designed to optimise production stability by protecting against the reproductive impact of the disease. REDUCES:

  • the negative reproductive disorders associated with PRRSV
  • the proportion of viraemic gilts / sows after exposure to PRRSV
  • viral load and the duration of viraemia in sows / gilts exposed to the virus
  • transplacental virus transmission from infected females to piglets
  • the negative impact of infection on piglets born to vaccinated sows in terms of mortality, clinical signs, and weight gain
  • ImpranFLEX® delivers an optimal balance of efficacy and safety

For more information click here.